Journal rankings · indicator year 2023
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2023
Epidemiology journal rankings 2023
199 ranked journals · Subfield in Medicine
Epidemiology has 199 ranked journals in 2023. The median journal has an OJR of 0.79, below the world average of 1.00, down 0.03 on 2022; Q1 starts at OJR 1.17. The top three are Journal of Hepatology, The Lancet. Gastroenterology & hepatology, and Nature Reviews Gastroenterology & Hepatology.
Ranks and citation indicators: 2023. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2020–2022, the window the 2023 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
Show all 42 subfields
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Hematology84
- Rheumatology67
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
199 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2022. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2020–2022, the window the 2023 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2020–2022 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2014 to 2023. | Compare |
|---|---|---|---|---|---|---|---|
1Journal of HepatologyElsevier BV · Denmark | 5.48Q1 | 16.13 0.77 down from 2022 | 1,182 | 16% | $5,500 | ||
2The Lancet. Gastroenterology & hepatologyElsevier BV · United Kingdom | 4.86Q1 | 14.58 1.45 down from 2022 | 535 | 31% | $7,280 | ||
3Nature Reviews Gastroenterology & HepatologyNature Portfolio · United Kingdom | 4.62Q1 | 18.21 6.29 down from 2022 | 451 | 24% | — | ||
4AutophagyTaylor & Francis · United States | 4.34Q1 | 11.10 0.37 down from 2022 | 603 | 100% | — | ||
5MetabolismElsevier BV · United States | 3.08Q1 | 10.93 0.96 up from 2022 | 430 | 33% | $5,340 | ||
6Clinical and Molecular HepatologyOAKorean Association for the Study of the Liver · South Korea | 2.53Q1 | 8.65 1.57 up from 2022 | 250 | 100% | $32 | ||
7International Journal of StrokeSAGE Publishing · United Kingdom | 2.37Q1 | 6.84 1.55 down from 2022 | 353 | 57% | $4,400 | ||
8StrokeLippincott Williams & Wilkins · United States | 2.26Q1 | 7.01 0.18 up from 2022 | 1,765 | 26% | — | ||
9PneumoniaOABioMed Central · United Kingdom | 2.19Q1 | 8.71 0.85 up from 2022 | 38 | 100% | $2,690 | ||
10Clinical Gastroenterology and HepatologyElsevier BV · United States | 2.18Q1 | 6.27 0.32 down from 2022 | 1,487 | 58% | $4,470 | ||
11European Stroke JournalSAGE Publishing · United Kingdom | 2.14Q1 | 7.49 0.53 up from 2022 | 195 | 100% | $4,400 | ||
12Infectious Disease Clinics of North AmericaElsevier BV · United States | 2.13Q1 | 7.75 2.27 up from 2022 | 148 | 27% | $4,050 | ||
13The Lancet Regional Health - Western PacificOAElsevier BV · United Kingdom | 2.03Q1 | 5.61 0.63 down from 2022 | 588 | 100% | $4,250 | ||
14Hepatology CommunicationsOALippincott Williams & Wilkins · United States | 2.02Q1 | 5.93 0.25 up from 2022 | 596 | 100% | $2,700 | ||
15Tumour Virus ResearchOAElsevier BV · Netherlands | 1.98Q1 | 5.73 1.73 up from 2022 | 30 | 100% | $3,110 | ||
16Stroke and Vascular NeurologyOABMJ · China | 1.90Q1 | 4.59 1.86 down from 2022 | 235 | 100% | $1,839 | ||
17Addictive Behaviors ReportsOAElsevier BV · United Kingdom | 1.84Q1 | 4.33 0.96 down from 2022 | 209 | 100% | $3,330 | ||
18Harm Reduction JournalOABioMed Central · United Kingdom | 1.83Q1 | 4.80 0.52 down from 2022 | 365 | 100% | $3,290 | ||
19International Breastfeeding JournalOABioMed Central · United Kingdom | 1.83Q1 | 4.50 1.21 down from 2022 | 284 | 100% | $3,090 | ||
20AddictionWiley · United Kingdom | 1.79Q1 | 4.94 0.33 down from 2022 | 911 | 88% | $4,600 | ||
21International Journal of Drug PolicyElsevier BV · Netherlands | 1.73Q1 | 4.71 0.03 down from 2022 | 902 | 72% | $4,350 | ||
22Seminars in Liver DiseaseThieme Medical Publishers (Germany) · United States | 1.72Q1 | 4.87 0.05 down from 2022 | 115 | 58% | — | ||
23Alimentary Pharmacology & TherapeuticsWiley · United Kingdom | 1.64Q1 | 5.46 0.41 down from 2022 | 951 | 85% | $5,250 | ||
24Substance Abuse Treatment Prevention and PolicyOABioMed Central · United Kingdom | 1.61Q1 | 4.05 0.10 down from 2022 | 255 | 100% | $3,090 | ||
25Expert Review of VaccinesOAInforma · United States | 1.58Q1 | 6.23 0.69 down from 2022 | 382 | 100% | — | ||
26Journal of StrokeOASouth Korea | 1.51Q1 | 4.22 1.63 down from 2022 | 155 | 100% | — | ||
27Psychology of Addictive BehaviorsAmerican Psychological Association · United States | 1.49Q1 | 3.58 0.28 down from 2022 | 299 | 56% | — | ||
28Journal of Intensive CareOABioMed Central · United Kingdom | 1.45Q1 | 3.66 1.71 down from 2022 | 285 | 100% | $2,577 | ||
29VaccineElsevier BV · United Kingdom | 1.45Q1 | 5.06 1.17 down from 2022 | 2,960 | 68% | $3,620 | ||
30European Addiction ResearchKarger Publishers · Switzerland | 1.45Q1 | 2.93 1.61 down from 2022 | 118 | 75% | — | ||
31Journal of Lower Genital Tract DiseaseLippincott Williams & Wilkins · United States | 1.42Q1 | 2.37 1.23 down from 2022 | 192 | 24% | — | ||
32Contemporary Drug ProblemsSAGE Publishing · United States | 1.41Q1 | 2.40 0.70 down from 2022 | 74 | 64% | $3,400 | ||
33The Italian Journal of Pediatrics/Italian journal of pediatricsOABioMed Central · United Kingdom | 1.40Q1 | 4.08 0.27 down from 2022 | 613 | 100% | $2,790 | ||
34Clinical EpidemiologyOADove Medical Press · New Zealand | 1.40Q1 | 3.90 0.27 down from 2022 | 377 | 100% | $2,836 | ||
35Veterinary ResearchOABioMed Central · United Kingdom | 1.39Q1 | 4.18 0.67 down from 2022 | 394 | 100% | $2,390 | ||
36Current Opinion in Infectious DiseasesLippincott Williams & Wilkins · United States | 1.38Q1 | 4.42 0.52 up from 2022 | 229 | 27% | — | ||
37Influenza and Other Respiratory VirusesOAWiley · United Kingdom | 1.36Q1 | 4.53 0.32 down from 2022 | 344 | 100% | $4,840 | ||
38Jornal de PediatriaOAElsevier BV · Brazil | 1.35Q1 | 3.06 0.85 down from 2022 | 284 | 100% | $1,800 | ||
39The Clinical NeuropsychologistTaylor & Francis · United Kingdom | 1.34Q1 | 3.33 0.96 down from 2022 | 283 | 40% | — | ||
40Journal of NeurotraumaMary Ann Liebert, Inc. · United States | 1.31Q1 | 3.89 0.43 down from 2022 | 664 | 48% | — | ||
41Journal of NeuroInterventional SurgeryBMJ · United Kingdom | 1.30Q1 | 4.19 0.68 down from 2022 | 919 | 34% | — | ||
42Journal of Multimorbidity and ComorbidityOASAGE Publishing · United Kingdom | 1.29Q1 | 3.67 1.82 up from 2022 | 48 | 100% | $1,575 | ||
43Alcoholism Clinical and Experimental ResearchWiley · United States | 1.28Q1 | 3.40 0.16 down from 2022 | 617 | 86% | $4,110 | ||
44Journal of VirologyOAAmerican Society for Microbiology · United States | 1.26Q1 | 4.14 1.41 down from 2022 | 1,923 | 100% | — | ||
45DiscoveriesOARomania | 1.26Q1 | 3.68 1.09 down from 2022 | 58 | 100% | — | ||
46Médecine et Maladies InfectieusesElsevier BV · France | 1.25Q1 | —no 2022 value | 71 | — | $1,713 | ||
47Journal of Clinical VirologyElsevier BV · Netherlands | 1.23Q1 | 4.12 5.87 down from 2022 | 607 | 63% | $4,210 | ||
48Journal of NeuroendocrinologyWiley · United Kingdom | 1.22Q1 | 3.74 0.38 up from 2022 | 364 | 78% | $4,550 | ||
49Ophthalmic and Physiological OpticsWiley · United Kingdom | 1.20Q1 | 3.04 0.09 down from 2022 | 367 | 83% | $4,050 | ||
50IntervirologyOAKarger Publishers · Switzerland | 1.17Q1 | 2.04 2.92 down from 2022 | 66 | 100% | $1,250 |
Subfields of Medicine, with Epidemiology highlighted.
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Hematology84
- Rheumatology67
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2023. Corpus-wide, 88.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
75 additional Epidemiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2020–2022, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2023. Publication window: 2020–2022. How these summaries are calculated
- Ranked journals
- 199
- Window papers (baseline)
- 217,205 +14.9% from indicator year 2020
- Median OJR
- 0.787 +1.5% from indicator year 2020
- Rising journals (2025)
- 17
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2020–2022 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 77 | 81 | 87 | 89 | 94 | 91 | 97 | 108 | 114 | 119 | 129 | 139 | 147 | 157 | 166 | 176 | 187 | 185 | 193 | 198 | 196 | 204 | 196 | 199 | 187 | 178 | |
| Window papers (baseline) | 48,701 | 54,887 | 59,554 | 64,149 | 67,383 | 74,616 | 83,633 | 94,079 | 103,216 | 113,942 | 125,223 | 136,221 | 144,307 | 149,052 | 156,773 | 162,831 | 168,650 | 170,014 | 174,699 | 179,855 | 189,056 | 200,238 | 212,651 | 217,205 | 217,754 | 220,321 | |
| Median OJR | 0.668 | 0.61 | 0.670 | 0.71 | 0.69 | 0.82223 | 0.85 | 0.8287 | 0.835 | 0.86 | 0.8293 | 0.830 | 0.87 | 0.844 | 0.836 | 0.795 | 0.82224 | 0.803 | 0.74 | 0.832 | 0.78 | 0.755 | 0.81 | 0.787 | 0.760 | 0.797 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.